United Therapeutics Corporation (UTHR) Insider Trading
- $999,400.80
- $773,721,457.77
- Nov. 11, 2024
- Martine A Rothblatt
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Nov. 21, 2022 | CEO | 8,000 | $266.93 | Sell | $2,135,440.00 | |
Nov. 18, 2022 | CEO | 8,000 | $263.97 | Sell | $2,111,760.00 | |
Nov. 14, 2022 | CEO | 8,000 | $258.17 | Sell | $2,065,360.00 | |
Nov. 8, 2022 | CEO | 7,680 | $262.70 | Sell | $2,017,536.00 | |
Nov. 7, 2022 | Director | 290 | $268.57 | Sell | $77,885.30 | |
Nov. 4, 2022 | CEO | 8,000 | $264.85 | Sell | $2,118,800.00 | |
Nov. 3, 2022 | EVP | 6,000 | $257.08 | Sell | $1,542,480.00 | |
Nov. 1, 2022 | Director | 700 | $230.28 | Sell | $161,196.00 | |
Oct. 20, 2022 | EVP | 6,000 | $216.68 | Sell | $1,300,080.00 | |
Oct. 6, 2022 | EVP | 6,000 | $209.26 | Sell | $1,255,560.00 | |
Oct. 3, 2022 | Director | 710 | $211.56 | Sell | $150,207.60 | |
Sept. 28, 2022 | Director | 850 | $211.05 | Sell | $179,392.50 | |
Sept. 22, 2022 | EVP | 6,000 | $203.34 | Sell | $1,220,040.00 | |
Aug. 23, 2022 | Director | 3,500 | $224.96 | Sell | $787,360.00 | |
Aug. 4, 2022 | EVP | 4,552 | $225.81 | Sell | $1,027,887.12 | |
July 21, 2022 | EVP | 6,000 | $226.27 | Sell | $1,357,620.00 | |
July 11, 2022 | N/A | 2,160 | $241.29 | Sell | $521,186.40 | |
July 11, 2022 | Director | 2,160 | $241.29 | Sell | $521,186.40 | |
July 7, 2022 | EVP | 6,000 | $242.04 | Sell | $1,452,240.00 | |
July 7, 2022 | EVP & GENERAL COUNSEL | 1,900 | $240.46 | Sell | $456,874.00 | |
June 27, 2022 | Director | 5,000 | $236.79 | Sell | $1,183,950.00 | |
June 16, 2022 | EVP | 6,000 | $215.58 | Sell | $1,293,480.00 | |
May 31, 2022 | CEO | 3,000 | $230.85 | Sell | $692,550.00 | |
May 27, 2022 | CEO | 3,000 | $231.27 | Sell | $693,810.00 | |
May 26, 2022 | Director | 5,000 | $223.54 | Sell | $1,117,700.00 | |
May 25, 2022 | CEO | 3,000 | $223.58 | Sell | $670,740.00 | |
May 23, 2022 | CEO | 3,000 | $209.61 | Sell | $628,830.00 | |
May 19, 2022 | EVP | 6,000 | $183.43 | Sell | $1,100,580.00 | |
May 5, 2022 | EVP | 6,000 | $190.65 | Sell | $1,143,900.00 | |
April 21, 2022 | EVP | 6,000 | $189.18 | Sell | $1,135,080.00 | |
April 7, 2022 | EVP | 6,000 | $185.52 | Sell | $1,113,120.00 | |
March 17, 2022 | EVP | 6,000 | $182.42 | Sell | $1,094,520.00 | |
March 3, 2022 | EVP | 6,000 | $174.12 | Sell | $1,044,720.00 | |
Feb. 17, 2022 | EVP | 6,000 | $202.17 | Sell | $1,213,020.00 | |
Feb. 3, 2022 | EVP | 6,000 | $200.10 | Sell | $1,200,600.00 | |
Jan. 20, 2022 | EVP | 6,000 | $205.57 | Sell | $1,233,420.00 | |
Jan. 6, 2022 | EVP | 6,000 | $192.46 | Sell | $1,154,760.00 | |
Dec. 29, 2021 | CEO | 3,082 | $212.49 | Sell | $654,894.18 | |
Dec. 27, 2021 | CEO | 3,082 | $213.31 | Sell | $657,421.42 | |
Dec. 22, 2021 | CEO | 3,082 | $202.44 | Sell | $623,920.08 | |
Dec. 20, 2021 | CEO | 3,082 | $200.00 | Sell | $616,400.00 | |
Dec. 16, 2021 | EVP | 6,000 | $195.53 | Sell | $1,173,180.00 | |
Dec. 2, 2021 | EVP | 6,000 | $189.36 | Sell | $1,136,160.00 | |
Nov. 24, 2021 | CEO | 3,083 | $200.64 | Sell | $618,573.12 | |
Nov. 22, 2021 | CEO | 3,083 | $200.42 | Sell | $617,894.86 | |
Nov. 15, 2021 | CEO | 3,083 | $203.45 | Sell | $627,236.35 | |
Nov. 10, 2021 | CEO | 3,083 | $200.00 | Sell | $616,600.00 | |
Nov. 8, 2021 | CEO | 3,083 | $200.94 | Sell | $619,498.02 | |
Nov. 8, 2021 | Director | 2,300 | $200.16 | Sell | $460,368.00 | |
Nov. 4, 2021 | CEO | 3,083 | $200.00 | Sell | $616,600.00 |
Insiders are both buying and selling United Therapeutics Corporation stock.
The insider traders at United Therapeutics Corporation are: Martine A Rothblatt, Paul A Mahon, Roger Jeffs, Martine A. Rothblatt, Martine Rothblatt, Christopher Causey, John Maxim Ferrari, Raymond Dwek, Christopher Patusky, Paul Mahon, David Zaccardelli, Richard Giltner, James Edgemond, Nilda Mesa, Louis W Sullivan, Tommy G Thompson, Judy D Olian, Michael Benkowitz, Ray Kurzweil, Paul A. Mahon, Louis Sullivan, R Paul Gray, Judy D. Olian, Tommy G. Thompson, DWEK RAYMOND, and MAHON PAUL A
The most active insider trader at United Therapeutics Corporation is Martine A Rothblatt with 386 trades.
Martine A Rothblatt has sold the most United Therapeutics Corporation stock with a total value of $372,318,923.20.
Martine A Rothblatt has bought the most United Therapeutics Corporation stock with a total value of $1,217,751.60.
The most recent insider trade for United Therapeutics Corporation was on Nov. 11, 2024.
The single biggest insider buy for United Therapeutics Corporation was from Martine A Rothblatt with a total value of $466,650.00 on Dec. 21, 2012.
The single biggest insider sell for United Therapeutics Corporation was from Michael Benkowitz with a total value of $8,084,500.00 on Aug. 7, 2024.